Babson Diagnostics’ BetterWay GLP-1 blood testing panel is now available at more than 25 Austin and Temple, Texas, retail locations, including Sam’s Club and Peoples Rx pharmacies. The panel features 29 tests to support GLP-1 therapy.
A study found that faster blood processing could double the detection of gestational diabetes, reducing complications for mothers and babies.
Scientists have developed a "band-aid" that measures biomarkers, including glucose levels, in sweat to monitor health conditions.
The clearance makes it possible for women who live with diabetes to receive monitoring of A1c, using laboratory tests performed on the Q-Pad.
Read More
A two-step screening protocol can effectively identify which patients with Type 2 diabetes need medication to prevent heart failure.
Read More
A new study evaluated the diagnostic value of certain markers before or at the time of screening for gestational diabetes mellitus.
Read More
Researchers developed a device that detects glucose and adenosine monophosphate (AMP) biomarkers in saliva with high sensitivity.
Read More
Researchers show that patients with central diabetes insipidus who lack anti-rabphilin-3A antibodies could be at risk of tumor development
Read More
Determining whether a person is diabetic could be as easy as having them speak a few sentences into their smartphone, a new study found.
Read More
Adding screening for type 2 diabetes in accident and emergency departments could uncover thousands of previously undiagnosed cases every year.
Read More
A prototype sensor that measures glucose levels in saliva could eventually offer a simple and painless way for people to monitor diabetes.
Read More
While A1c is the diagnostic gold standard for determining if a patient has diabetes, there are a variety of tests that provide flexibility.
Read More
ADLM, in collaboration with the ADA, released evidence-based guidelines to help diagnose patients with diabetes using the latest lab tools.Â
Read More
The U.S. FDA has granted a Breakthrough Device Designation for the Enhanced Liver Fibrosis (ELF) Test from Siemens Healthineers.
Read More
Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.
Read More
OmegaQuant has been awarded a grant to develop a dried blood spot test identifying fatty acid patterns that predict metabolic syndrome and type 2 diabetes as early screening tools.
Read More
New research from NIH found that blood glucose levels obtained at childhood examinations predicted future diabetes-related complications.
Read More
It’s hoped new understanding of the GCK gene and its role in the development of diabetes could help increase the usefulness of DNA sequencing.
Read More